PFE Stock Analysis: Buy, Sell, or Hold?
PFE - Pfizer Inc.
$26.48
-0.05 (-0.19%)
▼
5d:
-0.82%
30d:
-3.6%
90d:
-0.04%
HOLD
MODERATE Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Smart Money Accumulation
None View Scanner →
Strength: 7.9/10
Get Alerted When PFE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called PFE this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PFE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PFE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.85
Based on -0.5% avg growth
INTRINSIC VALUE TODAY
$15.43
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PFE is currently trading at $26.48, which is considered oversold relative to its 30-day fair value range of $26.51 to $27.72. The stock's valuation (Forward PE: 9.4) is in line with its historical norms (9.1). At these levels, the market is pricing in 1.0% annual earnings growth.
Technical Outlook: Technically, PFE is in a uptrend. The price is currently testing key support at $26.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PFE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PFE is in a uptrend. The price is currently testing key support at $26.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PFE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$26.51 -
$27.72
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.7%
Protect Your Profits
Holding PFE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($29.00)
- BULLISH: Expecting earnings turnaround to 1.0% growth with 5.4% revenue growth
Trading Range Analysis
30-Day Trading Range
$26.51 -
$27.72
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$26.01
Resistance Level
$27.58
Current Trend
Uptrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.41
Wall Street Target
$29.00
(+9.5%)
Revenue Growth (YoY)
5.4%
Earnings Growth (YoY)
-10.1%
Profit Margin
11.8%
Valuation Premium vs History
+1.0% premium
PE vs Historical
9.4 vs 9.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.0%
(market-implied from PE analysis)
1-Year Target
$26.74
(+1%)
2-Year Target
$27.01
(+2%)
3-Year Target
$27.28
(+3%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
PE COMPRESSION
$26.39
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: -5.1%)
$52.85
(+100%)
Base:
(SPY PE: 9.4, Growth: -5.1%)
$22.66
(-14%)
Bear:
(PE: 8.0, Growth: -5.1%)
$19.27
(-27%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 20.25 | Current EPS (TTM): $1.31
Bull Case
$58.37
(+120%)
Analyst growth 100.0%, PE expands to 22.3
Base Case
$53.06
(+100%)
Market implied 100.0%, PE stable at 20.3
Bear Case
$18.04
(-32%)
Severe decline -20.0%, PE contracts to 17.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 08, 2026 7:10 AM ET
Data refreshes hourly during market hours. Next update: 8:10 AM
Data refreshes hourly during market hours. Next update: 8:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PFE showing a specific setup today?
Insider Activity (6 Months)
2
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Gilbert Ray Cisneros, Jr.
SELL
2026-03-13
Gilbert Ray Cisneros, Jr.
BUY
2026-02-10
Ro Khanna
SELL
2026-01-22
Featured in Portfolios
PFE is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1202 | 57 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 67 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$250 | 61 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$215 | 62 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$353 | 59 HOLD |
Advanced PFE Option Strategies
Professional options setups generated by AI based on today's PFE price and gamma walls.
